Hematology
Fellowship
The training of Pediatric Hematology/Oncology/Blood and Marrow Transplantation (BMT) Fellows is coordinated through three divisions in the Department of Pediatrics -- the Division of Pediatric Hematology, the Division of Pediatric Oncology, and the division of Pediatric Blood & Marrow Transplantation. The overall objectives of the ACGME accredited Fellowship Program are to insure that the trainees will be competent in all aspects of Pediatric Hematology/Oncology/BMT as well as acquire the academic skills to continue in a tertiary Pediatric Hematology/Oncology/BMT environment. The trainee is expected to develop a thorough understanding of the pathophysiology of disorders related to Pediatric Hematology/Oncology/BMT and develop skills in the diagnosis, treatment, and management of these disorders. During their training, they additionally should become competent in developing skills related to the selection and evaluation of diagnostic procedures to carry out thorough evaluations of Pediatric Hematology/Oncology/BMT disorders.
This training program is designed to encourage trainees to develop an interest in clinical and basic research during the first year of training. The first year is almost exclusively devoted to clinical inpatient responsibilities. Approximately 40% is spent on the Pediatric Hematology service, 40% on the Pediatric Oncology service, and about 20% on the Pediatric BMT service. The Fellow is additionally assigned to a full day outpatient continuity clinic that he/she keeps for the entire three years. Fellows are responsible for following their own patients. Required selectives in blood banking, special hematology, immunogenetics, stem cell laboratory, apheresis, hematopathology and radiation oncology [LR1] occur in the first two months of the second year. The second and third years are devoted to research, either laboratory based or clinical research. The Fellows are encouraged to be a first author on a presentation of his/her research project at a national or international peer-review meeting by the end of the three years of training.
In addition to joining the fellowship program after three years of Pediatric residency, trainees now have the option of taking new modified training pathways that have been certified by the American Board of Pediatrics. The six alternative pathways are as follows: Special Alternative, Integrated Research, Accelerated Research, Subspecialty Fast-Tracking, Dual Subspecialty, and Combined Subspecialty. The Pediatric Hematology/Oncology/BMT Fellowship Program accepts candidates coming from any of these alternative pathways who have successfully completed the requirements therein. More information about these alternative pathways can be found on the American Board of Pediatrics’ website, www.abp.org.
See the links below to learn more about our Fellowship program.
Pediatric Hematology/Oncology/Blood and Marrow Transplantation Fellowship Training Program and Curriculum
As of July 2008, we will be participating in the online universal application process via ERAS. Please click on the link below to be directed to the ERAS website.
https://services.aamc.org/eras/erasstats/par/index.cfm
Click here for fellowship program details.
Contact Information
Darrell J. Yamashiro, MD, PhD
Associate Professor of Pediatrics and Pathology & Cell Biology
Director, Pediatric Hematology/Oncology Fellowship Program
dy39@columbia.edu
|